Medicines management 'rationalised' to cut pharma influence


NHS England is to create four regional committees to “rationalise” medicines evaluation in an attempt to reduce the influence of the pharmaceutical industry on commissioners’ spending and prescribing decisions.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here